Keyomarsi K - Search Results

1

Low-molecular-weight cyclin E can bypass letrozole-induced G1 arrest in human breast cancer cells and tumors.

Akli S, Bui T, Wingate H, Biernacka A, Moulder S, Tucker SL, Hunt KK, Keyomarsi K. Akli S, et al. Among authors: keyomarsi k. Clin Cancer Res. 2010 Feb 15;16(4):1179-90. doi: 10.1158/1078-0432.CCR-09-1787. Epub 2010 Feb 9. Clin Cancer Res. 2010. PMID: 20145171 Free PMC article.

2

Cyclin E and survival in patients with breast cancer.

Keyomarsi K, Tucker SL, Buchholz TA, Callister M, Ding Y, Hortobagyi GN, Bedrosian I, Knickerbocker C, Toyofuku W, Lowe M, Herliczek TW, Bacus SS. Keyomarsi K, et al. N Engl J Med. 2002 Nov 14;347(20):1566-75. doi: 10.1056/NEJMoa021153. N Engl J Med. 2002. PMID: 12432043 Free article.

3

Cyclin E is a more powerful predictor of breast cancer outcome than proliferation.

Keyomarsi K, Tucker SL, Bedrosian I. Keyomarsi K, et al. Nat Med. 2003 Feb;9(2):152. doi: 10.1038/nm0203-152. Nat Med. 2003. PMID: 12563321 No abstract available.

4

The low molecular weight (LMW) isoforms of cyclin E deregulate the cell cycle of mammary epithelial cells.

Wingate H, Bedrosian I, Akli S, Keyomarsi K. Wingate H, et al. Among authors: keyomarsi k. Cell Cycle. 2003 Sep-Oct;2(5):461-6. Cell Cycle. 2003. PMID: 12963845

5

Cyclin E and its low molecular weight forms in human cancer and as targets for cancer therapy.

Akli S, Keyomarsi K. Akli S, et al. Among authors: keyomarsi k. Cancer Biol Ther. 2003 Jul-Aug;2(4 Suppl 1):S38-47. Cancer Biol Ther. 2003. PMID: 14508079 Review.

6

Cyclin E deregulation alters the biologic properties of ovarian cancer cells.

Bedrosian I, Lu KH, Verschraegen C, Keyomarsi K. Bedrosian I, et al. Among authors: keyomarsi k. Oncogene. 2004 Apr 8;23(15):2648-57. doi: 10.1038/sj.onc.1207408. Oncogene. 2004. PMID: 15007381

7

Tumor-specific low molecular weight forms of cyclin E induce genomic instability and resistance to p21, p27, and antiestrogens in breast cancer.

Akli S, Zheng PJ, Multani AS, Wingate HF, Pathak S, Zhang N, Tucker SL, Chang S, Keyomarsi K. Akli S, et al. Among authors: keyomarsi k. Cancer Res. 2004 May 1;64(9):3198-208. doi: 10.1158/0008-5472.can-03-3672. Cancer Res. 2004. PMID: 15126360

8

Low-molecular-weight cyclin E: the missing link between biology and clinical outcome.

Akli S, Keyomarsi K. Akli S, et al. Among authors: keyomarsi k. Breast Cancer Res. 2004;6(5):188-91. doi: 10.1186/bcr905. Epub 2004 Jul 7. Breast Cancer Res. 2004. PMID: 15318923 Free PMC article.

9

The low molecular weight cyclin E isoforms augment angiogenesis and metastasis of human melanoma cells in vivo.

Bales E, Mills L, Milam N, McGahren-Murray M, Bandyopadhyay D, Chen D, Reed JA, Timchenko N, van den Oord JJ, Bar-Eli M, Keyomarsi K, Medrano EE. Bales E, et al. Among authors: keyomarsi k. Cancer Res. 2005 Feb 1;65(3):692-7. Cancer Res. 2005. PMID: 15705861

10

The tumor-specific hyperactive forms of cyclin E are resistant to inhibition by p21 and p27.

Wingate H, Zhang N, McGarhen MJ, Bedrosian I, Harper JW, Keyomarsi K. Wingate H, et al. Among authors: keyomarsi k. J Biol Chem. 2005 Apr 15;280(15):15148-57. doi: 10.1074/jbc.M409789200. Epub 2005 Feb 10. J Biol Chem. 2005. PMID: 15708847 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

146 results

Search Page

Filters